MedPath

The effects of ciprofloxacin on the treatment of bacterial otitis media

Phase 3
Conditions
Chronic bacterial otitis media.
Chronic mucoid otitis media
H65.3
Registration Number
IRCT20130427013136N7
Lead Sponsor
Babol University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Patients with chronic bacterial otitis media

Exclusion Criteria

Suspected Patients to mixed bacterial and fungal otitis
Suspected Patients to otomycosis
patients with external otitis
patients without rupture of the eardrum

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: Severity of pain will determined by the patient's expression or pain index (Visual Analog Scale-VAS) which are between 0-10.;Swelling. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: Severity of swelling will determine based on the examination of the ear by the physician.;Discharge. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: Severity of discharge will determine based on the examination of the ear by the physician.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath